Guillaume Mabilleau

Nantes Université, Univ Angers, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR 1229

Affiliated withNantes Université, Univ Angers, Oniris, CHU Nantes, INSERM, Regenerative Medicine and Skeleton, RMeS, UMR 1229 CHU Angers, Departement pathologie cellulaire et tissulaire

Research Area

Bioengineering

Biography

Guillaume Mabilleau has not added Biography.
If you are Guillaume Mabilleau and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title	2024

Other Publications

Article	Year
Depth and volume of resorption induced by osteoclasts generated in the presence of RANKL, TNF-alpha/IL-1 or LIGHT. Cytokine\| PubMed ID: 22172512	2012
Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties. Bone\| PubMed ID: 24594344	2014
Use of GLP-1 mimetic in type 2 diabetes mellitus: is it the end of fragility fractures? Endocrine\| PubMed ID: 25348148	2015
Glucose-dependent insulinotropic polypeptide (GIP) directly affects collagen fibril diameter and collagen cross-linking in osteoblast cultures. Bone\| PubMed ID: 25582623	2015
Alteration of the bone tissue material properties in type 1 diabetes mellitus: A Fourier transform infrared microspectroscopy study. Bone\| PubMed ID: 25813583	2015
Incretins and bone: friend or foe? Current opinion in pharmacology\| PubMed ID: 25917551	2015
A new stable GIP-Oxyntomodulin hybrid peptide improved bone strength both at the organ and tissue levels in genetically-inherited type 2 diabetes mellitus. Bone\| PubMed ID: 27062994	2016
High fat-fed diabetic mice present with profound alterations of the osteocyte network. Bone\| PubMed ID: 27312542	2016
Interplay between bone and incretin hormones: A review. Morphologie : bulletin de l'Association des anatomistes\| PubMed ID: 27423214	2017
Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption. Bone\| PubMed ID: 27451082	2016
Incretin-based therapy for the treatment of bone fragility in diabetes mellitus. Peptides\| PubMed ID: 29412811	2018
Sitagliptin Alters Bone Composition in High-Fat-Fed Mice. Calcified tissue international\| PubMed ID: 30564859	2019
Sclerostin antibody reduces long bone fractures in the oim/oim model of osteogenesis imperfecta. Bone\| PubMed ID: 31051315	2019
GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice. Peptides\| PubMed ID: 31765668	2020
Dapagliflozin and Liraglutide Therapies Rapidly Enhanced Bone Material Properties and Matrix Biomechanics at Bone Formation Site in a Type 2 Diabetic Mouse Model. Calcified tissue international\| PubMed ID: 32642787	2020
Predicting Bone Regeneration with a Simple Blood Test. Trends in molecular medicine\| PubMed ID: 33811008	2021
Osteomorphs as a tool for personalized medicine. Trends in endocrinology and metabolism: TEM\| PubMed ID: 33895074	2021
Validation of Fourier Transform Infrared Microspectroscopy for the Evaluation of Enzymatic Cross-Linking of Bone Collagen. Calcified tissue international\| PubMed ID: 37278762	2023
Gut hormone analogues and skeletal health in diabetes and obesity: Evidence from preclinical models. Peptides\| PubMed ID: 38657908	2024
Gut hormones and bone homeostasis: potential therapeutic implications. Nature reviews. Endocrinology\| PubMed ID: 38858581	2024